Relapse and its remission in Japanese patients with idiopathic membranous nephropathy

Clinical and Experimental Nephrology

Volumn 19, Issue 2, 2015, Pages 278-283

  Kitajima, Shinji ^a,b,c   Furuichi, Kengo ^a,b,c   Sakai, Norihiko ^a,b,c   Sagara, Akihiro ^a,b,c   Shinozaki, Yasuyuki ^a,b,c   Toyama, Tadashi ^a,b,c   Iwata, Yasunori ^a,b,c   Shimizu, Miho ^a,b,c   Yokoyama, Hitoshi ^a,b,c   Kaneko, Shuichi ^a,b,c   Wada, Takashi ^a,b,c  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Electron dense deposit; MN; Relapse; Remission

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; CHILD; COMPLICATION; ELECTRON MICROSCOPY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS, MEMBRANOUS; HUMAN; JAPAN; MALE; MIDDLE AGED; PATHOLOGY; PROTEINURIA; RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; PROTEINURIA; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84939873947     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-014-0987-9     Document Type: Article

References (21)

1. Noel LH, Zanetti M, Droz D, Barbanel C. Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. Am J Med. 1979;66:82–90.
2. Kida H, Asamoto T, Yokoyama H, Tomosugi N, Hattori N. Long-term prognosis of membranous nephropathy. Clin Nephrol. 1986;25:64–9.
3. Cameron JS. Membranous nephropathy—still a treatment dilemma. N Engl J Med. 1992;327:638–9.
4. Marx BE, Marx M. Prognosis of idiopathic membranous nephropathy: a methodologic meta-analysis. Kidney Int. 1997;51:873–9.
5. Ogi M, Yokoyama H, Tomosugi N, et al. Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome. Am J Kidney Dis. 1994;24:427–36.
6. Reichert LJM, Koene RAP, Wetzels JF. Prognostic factor in idiopathic membranous nephropathy. Am J Kidney Dis. 2001;31:1–11.
7. Wu Q, Jinde K, Nishina M, et al. Analysis of prognostic predictors in idiopathic membranous nephropathy. Am J Kidney Dis. 2001;37:380–7.
8. Wakai S, Magil AB. Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney Int. 1992;41:428–34.
9. Marx BE, Marx M. Prediction of idiopathic membranous nephropathy. Kidney Int. 1999;56:666–73.
10. Ehrenreich T, Churg J. Pathology of membranous nephropathy. Pathol Ann. 1968;3:145–86.
11. Ehrenreich T, Porush JG, Churg J, et al. Treatment of idiopathic membranous nephropathy. N Engl J Med. 1976;295:741–6.
12. Yokoyama H, Goshima S, Wada T, et al. The short- and long-term outcomes of membranous nephropathy treated with intravenous immune globulin therapy. Nephrol Dial Transplant. 1999;14:2379–86.
13. Yoshimoto K, Yokoyama H, Wada T, et al. Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy. Kidney Int. 2004;65:148–53.
14. Rosen S, Tornroth T, Bernard DB. Membranous glomerulonephritis. In: Tisher CC, Brenner BM, editors. Renal pathology with clinical and functional correlations. Philadelphia: JB Lippincott Company; 1989. p. 196–227.
15. Manos J, Short CD, Acheson EJ, et al. Relapsing idiopathic membranous nephropathy. Clin Nephrol. 1982;18:286–90.
16. Tornroth T, Honaken E, Pettersson E. The evolution of membranous glomerulonephritis reconsidered: new insight from a study on relapsing disease. Clin Nephrol. 1987;28:107–17.
17. Ponticelli C, Passerini P, Altieri P, Locatelli F, Pappalettera M. Remissions and relapses in idiopathic membranous nephropathy. Nephrol Dial Transplant. 1992;7:85–90.
18. Wadi N, Trimarchi H, Pedro J. Relapsing membranous nephropathy. Am J Nephrol. 2001;31:1–11.
19. Eriguchi M, Oka H, Kamimura T, Sugawara K, Harada A. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and predonisolone. Nephrol Dial Transplant 2009;24:3082–8.
20. Yuan J, Fang W, Zhang W, Ni Z, Qian J. Treatment of nephrotic idiopathic membranous nephropathy with monthly i.v. pulse cyclophosphamide and oral steroids: a single center’s retrospective study. Nephrology. 2011;16:440–5.
21. Bohdan J, Cattran C. Prognosis after complete remission in adult patients with idiopathic membranous nephropathy. Am J Kidney Dis. 1999;33:1026–32.